Brexit’s Impact on Healthcare and Life Sciences

British PillHealth and life sciences are heavily regulated sectors, which directly employ a significant proportion of the workforce across health and care delivery, pharmaceuticals, research and development, education, animal health and the many other issues covered by the sector. The sector drives a significant percentage of trade inside and outside the EU market and healthcare consumes, on average, 10 per cent of national budgets across the EU.

In this snapshot we analyse how Brexit could impact this important sector.

Petra Wilson is Senior Advisor at FTI Consulting in Brussels and Alex Deane is Managing Director in FTI Consulting’s Public Affairs team in London.

Share This Post


Related by categories

Related by tags



No comments yet.